株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

中国のタクロリムス市場の分析

Investigation Report on China Tacrolimus Market, 2010-2019

発行 China Research and Intelligence 商品コード 296866
出版日 ページ情報 英文 30 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=114.58円で換算しております。
Back to Top
中国のタクロリムス市場の分析 Investigation Report on China Tacrolimus Market, 2010-2019
出版日: 2015年06月11日 ページ情報: 英文 30 Pages
概要

タクロリムス(別名:FK506、FR-900506)は、藤沢薬品工業(山之内製薬との合併で、現在はアステラス製薬)によって開発されました。1993年6月に「プログラフ」として日本で初めて承認されました。タクロリムスは免疫抑制剤で、主に同種臓器移植の後に使われ、患者の免疫系の働きを抑制し、臓器拒絶反応のリスクを低下させます。1994年にFDAに承認され、現在は複数の国と地域市場で販売されています。1998年には、タクロリムス製剤(注射とカプセル)の中国への輸入が承認されました。

当レポートでは、中国におけるタクロリムス市場について調査分析し、主要メーカーの市場シェア、病院市場での販売価格、主要メーカーのプロファイル、病院市場での市場シェア(剤形別)、市場の見通しなどを提供いたします。

第1章 タクロリムスの関連概念

  • 適応
  • 世界市場の販売状況

第2章 中国におけるタクロリムスの市場概要

  • 特許および承認の状況
  • 主要メーカー
  • 市場規模

第3章 中国におけるタクロリムスの売上高の分析

  • 総売上高
  • 売上高:地域別

第4章 中国におけるタクロリムスの販売量の分析

  • 総販売量
  • 販売量:地域別

第5章 中国におけるタクロリムスの主要メーカーの市場シェアの分析

  • 市場シェア:売上高別
  • 市場シェア:販売量別

第6章 中国におけるタクロリムス(剤形別)の市場規模の分析

  • 市場シェア:売上高・剤形別
  • 市場シェア:販売量・剤形別

第7章 中国の病院市場におけるタクロリムスの基準価格

  • Astellas Pharma Manufacturing,Inc.(US)
  • 千寿製薬
  • Sichuan Med-Shine Pharmaceutical Co., Ltd
  • Sinopharm Chuankang Pharmaceutical Co., Ltd
  • 山之内製薬
  • Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
  • Zhejiang Hisun Pharmaceutical Co.,Ltd.
  • 藤沢薬品工業

第8章 中国におけるタクロリムスの主要メーカー

  • アステラス製薬
  • Zhejiang Hisun Pharmaceutical Co., Ltd.
  • Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
  • Sichuan Med-Shine Pharmaceutical Co., Ltd
  • 山之内製薬

第9章 中国のタクロリムス市場の見通し

  • 市場規模の予測
  • 競合パターンの予測

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: 1506204

Tacrolimus (also FK506) is a macrolide lactone immunosuppressive drug discovered from a soil sample that contained the bacterium Streptomyces tsukubaensis in 1984 by Fujisawa Pharmaceutical Co., Ltd. Tacrolimus acts like cyclosporine and its systemic use is mainly for the prevention of allograft rejection and the treatment of immune disease. Different from cyclosporine, it can penetrate through epidermis barrier due to its relatively small molecular mass. Therefore to avoid systemic adverse reactions, it can be made into external preparation to treat various immune inflammatory cutaneous disorders.

After entering China in 1999, tacrolimus develops fast with annual sales rising from less than CNY 100 million in 2005 to CNY 688 million in 2014 and CAGR reaching up to 24.7% during this period. Tacrolimus in the Chinese market are in four formulations: injection, capsule, eye drop and ointment, among which the sales value of capsules takes up over 90% of the sum in 2014. Tacrolimus is used for a variety of indications, for example, capsules are mainly used to prevent graft rejection after liver or kidney transplantation.

Tacrolimus in the Chinese market mainly comes from the following companies: Fujisawa Pharmaceutical Co., Ltd (Ireland), Hisun, Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd, Sichuan Med-Shine Pharmaceutical Co., Ltd and Astellas Pharma Manufacturing,Inc, among which Fujisawa Pharmaceutical Co., Ltd (Ireland) has the largest market share of 75.40% by sales value in 2014.

As the number of organ transplants and the number of the cases of immune disease increase, the sales value of tacrolimus in China is expected to keep growing.

Readers can get at least the following information from this report:

  • market share of manufacturers of tacrolimus in China
  • price of tacrolimus in Chinese market
  • major manufacturers of tacrolimus in Chinese market
  • share of dosage forms of tacrolimus in China
  • market outlook of tacrolimus in China

The author suggests the following groups of people purchase this report:

  • manufacturers of immunosuppressants
  • investors/ research institutions interested in Chinese medicine market
  • any interest in the Chinese medicine market, please contact CRI for customized survey service

Table of Contents

1. Related Concepts of Tacrolimus

  • 1.1. Indication
  • 1.2. Developments in Global Market

2. Market Profile of Tacrolimus in China

  • 2.1. Patent and Approval Status of Tacrolimus in China
  • 2.2. Major Manufacturers
  • 2.3. Market Size

3. Survey on Sales Value of Tacrolimus in China, 2010-2014

  • 3.1. Overall Sales Value
  • 3.2. Sales Value by Regions

4. Survey on Sales Volume of Tacrolimus in China, 2010-2014

  • 4.1. Overall Sales Volume
  • 4.2. Sales Volume by Regions

5. Survey on Market Share of Major Manufacturers of Tacrolimus in China, 2010-2014

  • 5.1. Market Share by Sales Value
  • 5.2. Market Share by Sales Volume

6. Survey on Market Size of Dosage Forms of Tacrolimus in China, 2010-2014

  • 6.1. Market Share of Different Dosage Forms by Sales Value
  • 6.2. Market Share of Different Dosage Forms by Sales Volume

7. Reference Retail Price of Tacrolimus in China in 2014

  • 7.1. Astellas Pharma Manufacturing,Inc.(US) (Trade Name: Prograf)
  • 7.2. Senju Pharmaceutical Co., Ltd (Japan) (Trade Name: Protopic)
  • 7.3. Sichuan Med-Shine Pharmaceutical Co., Ltd (Trade Name: Ming Zhi Xin)
  • 7.4. Sinopharm Chuankang Pharmaceutical Co., Ltd (Trade Name: Yi Li Kang)
  • 7.5. Yamanouchi Pharmaceutical Co., Ltd (Japan)
  • 7.6. Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
  • 7.7. Zhejiang Hisun Pharmaceutical Co.,Ltd.
  • 7.8. Fujisawa Pharmaceutical Co., Ltd (Ireland) (Trade Name: Prograf)

8. Major Manufacturers of Tacrolimus in the Chinese Market, 2010-2014

  • 8.1. Astellas Pharma Manufacturing,Inc.
  • 8.2. Zhejiang Hisun Pharmaceutical Co.,Ltd.
  • 8.3. Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
  • 8.4. Sichuan Med-Shine Pharmaceutical Co., Ltd
  • 8.5. Yamanouchi Pharmaceutical Co., Ltd (Japan)

9. Market Outlook of Tacrolimus in China, 2014-2018

  • 9.1. Forecast of Market Size
  • 9.2. Forecast of Competitive Landscape

Selected Charts

  • Chart Patent Status of Tacrolimus in China
  • Chart Approval Information of Tacrolimus in China
  • Chart Sales Status of Tacrolimus in China, 2010-2014
  • Chart Sales Value of Tacrolimus in China, 2010-2014
  • Chart Sales Value of Tacrolimus in Some Regions in China, 2010-2014
  • Chart Market Share of TOP5 Manufacturers of Tacrolimus for Sales Value in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Made by Fujisawa (Ireland) in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Made by Hangzhou Zhongmei Huadong in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Made by Yamanouchi (Japan) in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Made by Hisun in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Injections in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Eye Drops in China, 2010-2014
  • Chart Sales Value and Market Share of Tacrolimus Capsules in China, 2010-2014
  • Chart Price of Tacrolimus Made by Astellas Pharma Manufacturing,Inc.(US) in Some Regions in China
  • Chart Price of Tacrolimus Made by Senju Pharmaceutical Co., Ltd (Japan) in Some Regions in China
  • Chart Price of Tacrolimus Made by Yamanouchi Pharmaceutical Co., Ltd (Japan) in Some Regions in China
  • Chart Price of Tacrolimus Made by Zhejiang Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd in Some Regions in China
  • Chart Price of Tacrolimus Made by Hisun in Some Regions in China
  • Chart Price of Tacrolimus Made by Fujisawa Pharmaceutical Co., Ltd (Ireland) in Some Regions in China
Back to Top